Search the Newsreel

Sinopec Kantons Sets August Board Meeting to Approve Interim Results and Dividend

5 Insightful Analyst Questions From Avantor’s Q2 Earnings Call

Antofagasta (LSE:ANTO) Highlights Tension Between Copper Demand And Water Constraints

Avantor (NYSE: AVTR) CAO has 1,385 shares withheld for taxes

Avantor, Inc.'s SVP & Chief Accounting Officer, Steven W. Eck, had 1,385 shares of common stock withheld on July 31, 2026, to cover tax obligations related to the vesting of Restricted Stock Units (RSUs). The shares were valued at $13.78 each. Following this transaction, …

Price to earnings forward of Flour Mills C. Sarantopoulos SA – ATHEX:KYSA

AVTR|Avantor Inc|Price:13.675|Chg%:-0.105

This article provides a comprehensive stock analysis of Avantor Inc (AVTR) by TradingKey, highlighting its healthy fundamentals, high growth potential, and "fairly valued" status. Despite strong market performance and fundamentals, technical indicators don't fully support the current trend, with the stock trading sideways. The …

Avantor, Inc. (AVTR) Just Flashed Golden Cross Signal: Do You Buy?

Avantor, Inc. (AVTR) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, AVTR's 50-day simple moving average broke out above its 200-day moving average; this is known as a "golden cross." A golden cross is …

Securities Lawsuit Alert: Avantor, Inc. (AVTR) – Contact Levi & Korsinsky Before December 29, 2025

Levi & Korsinsky, LLP has filed a class action securities lawsuit against Avantor, Inc. (NYSE:AVTR), seeking to recover losses for shareholders who purchased stock between March 5, 2024, and October 28, 2025. The lawsuit alleges that Avantor made false statements regarding its competitive position …

Are Medical Stocks Lagging Avantor (AVTR) This Year?

Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Is Avantor, Inc. (AVTR) one of those stocks right now? Let's take a closer look at the stock's year-to-date performance to find out. Avantor, Inc. is a …

Avantor, Inc. Revenue Breakdown – DUS:AVG

Avantor, Inc. (DUS:AVG) generated €5.58 billion in revenue last year, primarily from its Laboratory Solutions segment, which accounted for €3.75 billion. The United States was the largest geographical contributor, bringing in €2.79 billion. This information highlights the company's key revenue streams by segment and …

Why Avantor (AVTR) Is Up 20.5% After Raising 2026 Guidance Despite Weaker GAAP Earnings

Avantor (AVTR) saw its stock rise 20.5% after raising its full-year 2026 sales and earnings guidance, despite reporting weaker GAAP net income and earnings per share in Q2 2026. This positive market reaction is attributed to better-than-expected adjusted results, improved organic growth in VWR …

Avantor, Inc. (AVTR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Avantor, Inc. (AVTR) for alleged corporate wrongdoing. The firm encourages stockholders who purchased Avantor securities before March 5, 2024, and still hold them, to contact them to assist with the investigation. The firm operates …

avantor, inc Positive Earnings Pre-Announcements

Avantor, Inc. (AVTR) has pre-announced positive earnings for FY26, with an estimated range of $0.80 to $0.83 per share, an increase from its prior estimate of $0.77 to $0.83. This news comes amidst other company updates, including past quarterly profit retreats and leadership changes. …

Cantor Equity Partners IV (CEPF) Holds at $10.41 as SPAC Investors Await Merger Catalyst - Unusual Call Volume

Avantor (AVTR) Is Up 20.5% After Raising 2026 Guidance On Stronger VWR Organic Growth – Has The Bull Case Changed?

Avantor, Inc. reported past second-quarter 2026 results showing sales of US$1,692.3 million, slightly above a year earlier, while net income and earnings per share from continuing operations declined versus the prior-year period. Despite softer profitability under GAAP, Avantor's adjusted earnings and revenue exceeded analyst …

Santos Stock And 2 Energy Names Exposed To Oil Route Risks

Avantor, Inc. 2026 Q2 - Results - Earnings Call Presentation (NYSE:AVTR) 2026-07-31

Avantor, Inc. published its Q2 2026 earnings call presentation on July 31, 2026. The company reported an EPS of $0.21, beating estimates by $0.02, and revenue of $1.69 billion, a 0.53% year-over-year increase, beating estimates by $84.65 million. This article provides access to the …

AVTR Q2 Deep Dive: Strategic Initiatives and Segment Execution Drive Guidance Increase

AVTR Q2 Deep Dive: Strategic Initiatives and Segment Execution Drive Guidance Increase Life sciences company Avantor (NYSE:AVTR) beat Wall Street's revenue expectations in Q2 CY2026, but sales were flat year on year at $1.69 billion. Its non-GAAP profit of $0.21 per share was 11% …

Avantor Stock Surged Because One Segment Stopped Shrinking

Avantor (AVTR) stock surged 15.8% after its June quarter results, driven by its VWR distribution segment returning to organic growth, despite overall organic revenue still contracting slightly. The company raised its 2026 organic revenue and adjusted earnings guidance. However, the smaller bioscience and medtech …

Avantor Q2 Earnings Beat Estimates on VWR Growth, Guidance Raised

Avantor, Inc. AVTR reported second-quarter 2026 adjusted earnings per share (EPS) of 21 cents, down 12.5% from the year-ago quarter. However, the bottom line surpassed the Zacks Consensus Estimate by 10.5%. GAAP EPS for the quarter was 6 cents, down from 9 cents per …

Deutsche Bank Adjusts Avantor Price Target to $13 From $11, Maintains Hold Rating

Deutsche Bank has updated its price target for Avantor (AVTR), increasing it to $13 from the previous $11, while keeping a "Hold" rating on the stock. This adjustment reflects a modest increase in the valuation outlook for the life sciences tools and services company. …

Wolfe Research upgrades Avantor stock rating on improved outlook

Wolfe Research upgraded Avantor Inc. (NYSE:AVTR) to Peerperform from Underperform, citing improved end market conditions and progress in the company's turnaround efforts, especially after better-than-expected Q2 results. Despite a recent stock surge and increased investor confidence, InvestingPro analysis suggests the shares may be overvalued …

Avantor, Inc. Stock 12‑Month Price Target Raised to $11.66, Implies 6% Downside

Avantor, Inc. (AVTR) stock's average 12-month price target has been increased from $10.44 to $11.66 by 16 analysts, with forecasts ranging from $7 to $19 per share. This updated target suggests a potential 6% downside based on the July 28 closing price. Despite the …

Are Antofagasta (LSE:ANTO) And Rio (LSE:RIO) Defining The UK Metals and Mining Stocks Story?

Avantor (AVTR) Stock Slips As Turnaround Progress Meets Profit Drop

Avantor Inc (AVTR) Institutional Confidence

Avantor Inc (AVTR) has received a high institutional confidence score of 10.00, placing it at the top of the Healthcare Equipment & Supplies industry. This score reflects a significant institutional shareholding proportion of 104.03%, despite a quarter-over-quarter decrease of 11.03%. Barrow Hanley is the …

Sinopec Kantons Holdings (SEHK:934) Flags Profit Drop As Valuation Questions Return

Avantor (AVTR) Stock Climbs As Analysts Hike Targets Ahead Q2

Avantor (AVTR) stock has climbed by 13.77% after analysts from firms like BofA, TD Cowen, Citi, and Evercore ISI hiked their price targets ahead of its Q2 2026 earnings release. While most firms maintain a Neutral/Hold rating, the increased targets and positive macro trends …

Avantor Inc (AVTR) Q2 2026 Earnings Call Highlights: Strategic Growth and Financial Resilience

This article first appeared on GuruFocus. Revenue: $1.69 billion, declined 0.4% organically, up 0.5% on a reported basis. VWR Segment Revenue: $1.24 billion, up 1.7% organically. BMP Segment Revenue: $452 million, down 5.6% organically. Adjusted EBITDA: $254 million, margin of 15%. Adjusted Earnings Per …

Cantor Equity Partners V Inc. (NASDAQ:CEPV) Short Interest Down 45.7% in July

Cantor Equity Partners V Inc. (NASDAQ:CEPV) experienced a significant 45.7% decline in short interest during July, falling to 620 shares. Despite this, the stock traded down 0.2% to $10.43, and analyst sentiment remains largely negative with an average "Sell" rating. Several institutional investors, however, …

Avantor Stock Climbs As Analysts Hike Targets And NuSil Expands

Avantor Inc. (AVTR) stock has risen by 14.21% due to strong demand in life sciences and company expansion, with analysts raising price targets into the $10.50-$12 range. The company's NuSil brand is expanding its partnership with the Population Council on an HIV prevention ring. …

Avantor (AVTR) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

For the quarter ended June 2026, Avantor, Inc. (AVTR) reported revenue of $1.69 billion, up 0.5% over the same period last year. EPS came in at $0.21, compared to $0.24 in the year-ago quarter. The reported revenue represents a surprise of +4.17% over the …

Avantor, Inc. Q2 2026: Revenue $1.69B, EPS $0.06— 10-Q Summary

Avantor, Inc. reported Q2 2026 results with revenue of $1.69 billion, nearly flat year-over-year, and diluted EPS of $0.06, down from $0.09 in the prior year. The company experienced margin pressure and mixed demand, leading to a decline in net income. While VWR Distribution …

Avantor Releases Q2 2026 Financial Results

Avantor, Inc. reported Q2 2026 adjusted earnings per share of $0.21, surpassing analyst estimates by 10.5%. The company achieved $1.69 billion in revenue, a slight increase from Q2 2025, despite a 0.4% decline in organic revenue due to biopharma and research market headwinds. Avantor …

Avantor, Inc. (AVTR) Beats Q2 Earnings and Revenue Estimates

Avantor, Inc. (AVTR) came out with quarterly earnings of $0.21 per share, beating the Zacks Consensus Estimate of $0.19 per share. This compares to earnings of $0.24 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an …

Avantor (NYSE:AVTR) Delivers Impressive Q2 CY2026, Stock Soars

Avantor (NYSE:AVTR) Delivers Impressive Q2 CY2026, Stock Soars Life sciences company Avantor (NYSE:AVTR) beat Wall Street's revenue expectations in Q2 CY2026, but sales were flat year on year at $1.69 billion. Its non-GAAP profit of $0.21 per share was 11% above analysts' consensus estimates. …